Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation.

Bingsong Huang,Jun Liu,Jun Li,Paul M Schroder,Maogen Chen,Ronghai Deng,Suxiong Deng

Journal of the American Pharmacists Association（2019）

引用 2|浏览29

暂无评分

摘要

Current evidence suggests that TAC qd is safe and effective for LT patients during the first year after transplantation. Longer-term follow-up studies are necessary to determine if TAC qd is safe and effective beyond the first year after LT.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要